IGF1 is a common target gene of Ewing's sarcoma fusion proteins in mesenchymal progenitor cells

PLoS ONE

Volumn 3, Issue 7, 2008, Pages

  Cironi, Luisa ^a   Riggi, Nicolò ^a   Provero, Paolo ^b   Wolf, Natalie ^a   Suvà, Mario Luca ^a   Suvà, Domizio ^c   Kindler, Vincent ^c   Stamenkovic, Ivan ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITY OF TURIN   (Italy)

^c UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

HYBRID PROTEIN; SOMATOMEDIN C; TRANSCRIPTION FACTOR ER81; TRANSCRIPTION FACTOR ERG; TRANSCRIPTION FACTOR ETS; TRANSCRIPTION FACTOR ETV6; TRANSCRIPTOME; EWS ERG FUSION PROTEIN, HUMAN; EWS FLI1 FUSION PROTEIN; EWS-ERG FUSION PROTEIN, HUMAN; EWS-FLI1 FUSION PROTEIN; ONCOPROTEIN; RNA BINDING PROTEIN; TLS ERG FUSION PROTEIN, HUMAN; TLS-ERG FUSION PROTEIN, HUMAN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FLI 1;

ANIMAL CELL; ARTICLE; CANCER GROWTH; CELL ISOLATION; CONTROLLED STUDY; DISEASE ASSOCIATION; EWING SARCOMA; GENE ACTIVATION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE INDUCTION; GENE REPRESSION; GENE TARGETING; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; PATHOGENESIS; PROMOTER REGION; PROTEIN EXPRESSION; ANIMAL; BIOLOGICAL MODEL; C57BL MOUSE; CHEMISTRY; CYTOLOGY; GENE EXPRESSION REGULATION; HUMAN; METABOLISM; PHENOTYPE;

ANIMALS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MESENCHYMAL STEM CELLS; MICE; MICE, INBRED C57BL; MODELS, BIOLOGICAL; ONCOGENE PROTEINS, FUSION; PHENOTYPE; PROMOTER REGIONS (GENETICS); PROTO-ONCOGENE PROTEIN C-FLI-1; RNA-BINDING PROTEIN FUS; TRANSCRIPTION FACTORS;

EID: 49949085240     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0002634     Document Type: Article

References (39)

1. Helman LJ, Meltzer P (2003) Mechanisms of sarcoma development. Nat Rev Cancer 3: 685-694.
2. Riggi N, Stamenkovic I (2007) The Biology of Ewing sarcoma. Cancer Lett 254: 1-10.
3. Delattrc O, Zucman J, Plougastel B, Desmaze C, Mclot T, et al. (1992) Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours. Nature 359: 162-165.
4. Riggi N, Cironi L, Suva ML, Stamenkovic I (2007) Sarcomas: genetics, signalling, and cellular origins. Part 1: The fellowship of TET. J Pathol 213: 4-20.
5. Thompson AD, Teitell MA, Arvand A, Denny CT (1999) Divergent Ewing's sarcoma EWS/ETS fusions confer a common tumorigenic phenotype on NIH3T3 cells. Oncogene 18: 5506-5513.
6. Deneen B, Denny CT (2001) Loss of p16 pathways stabilims EWS/FLI1 expression and complements EWS/FLI1 mediated transformation. Oncogene 20: 6731-6741.
7. Lessnick SL, Dacwag CS, Golub TR (2002) The Ewing's sarcoma oncoprotein EWS/FIJ induces a p53-dependent growth arrest in primary human fibroblasts. Cancer Cell 1: 393-401.
8. Riggi N, Cironi L, Provero P, Suva ML, Kaloulis K, et al. (2005) Development of Ewing's sarcoma from primary bone marrow-derived mesenchymal progenitor cells. Cancer Res 65: 11459-11468.
9. May WA, Arvand A, Thompson AD, Braun BS, Wright M, et al. (1997) EWS/ FLI1-induced manic fringe renders NIH 3T3 cells tumorigenic. Nat Genet 17: 495-497.
10. Zwerner JP, Guimbellot J, May WA (2003) EWS/FLI function varies in different cellular backgrounds. Exp Cell Res 290: 414-419.
11. Shing DC, McMullan DJ, Roberts P, Smith K, Chin SF, et al. (2003) FUS/ ERG gene fusions in Ewing's rumors. Cancer Res 63: 4568-4576.
12. Welford SM, Hebert SP, Deneen B, Arvand A, Denny CT (2001) DNA binding domain-independent pathways are involved in EWS/FLI1-mediated oncogenesis. J Biol Chem 276: 41977-41984.
13. Lessnick SL, Braun BS, Denny CT, May WA (1995) Multiple domains mediate transformation by the Ewing's sarcoma EWS/FLI-1 fusion gene. Oncogene 10: 423-431.
14. May WA, Gishizky ML, Lessnick SL, Lunsford LB, Lewis BG, et al. (1993) Ewing sarcoma 11;22 translocation produces a chimeric transcription factor that requires the DNA-binding domain encoded by FLI1 for transformation. Proc Natl Acad Sci U S A 90: 5752-5756.
15. Baird K, Davis S, Antonescu CR, Harper UL, Walker RL, et al. (2005) Gene expression profiling of human sarcomas: insights into sarcoma biology. Cancer Res 65: 9226-9235.
16. Alfieri CM, Evans-Anderson HJ, Yutzey KE (2007) Developmental regulation of the mouse IGF-I exon 1 promoter region by calcineurin activation of NFAT in skeletal muscle. Am J Physiol Cell Physiol 292: C1887-1894.
17. Riggi N, Suva ML, Suva D, Cironi L, Provero P, et al. (2008) EWS-FLI-1 expression triggers a Ewing's sarcoma initiation program in primary human mesenchymal stem cells. Cancer Res 68: 2176-2185.
18. Tirode F, Laud-Duval K, Prieur A, Delorme B, Charbord P, et al. (2007) Mesenchymal stem cell features of Ewing tumors. Cancer Cell 11: 421-429.
19. Wynes MW, Riches DW (2005) Transcription of macrophage IGF-I exon 1 is Positively regulated by the 5′-untranslated region and negatively regulated by the 5′-flanking region. Am J Physiol Lung Cell Mol Physiol 288: L1089-1098.
20. Mittanck DW, Kim SW, Rotwcin P (1997) Essential promoter elements are located within the 5′ untranslated region of human insulin-like growth factor-I exon I. Mol Cell Endocrinol 126: 153-163.
21. Gerald VVL, Haber DA (2005) The EWS-WT1 gene fusion in desmoplastic small round cell tumor. Semin Cancer Biol 15: 197-205.
22. Scherf M, Klingenhoff A, Werner T (2000) Highly specific localization of promoter regions in large genomic sequences by PromoterInspector: a novel context analysis approach. J Mol Biol 297: 599-606.
23. Castillero-Trejo Y, Eliazer S, Xiang L, Richardson JA, Ilaria RI, Jr (2005) Expression ofthe EWS/FLI-1 oncogene in murine primary bone-derived cells Results in EWS/FLI-1-dependent, ewing sarcoma-like tumors. Cancer Res 65: 8698-8705.
24. Araya N, Hirota K, Shimamoto Y, Miyagishi M, Yoshida E, et al. (2003) Cooperative interaction of EWS with CREB-binding protein selectively activates hepatocyte nuclear factor 4-mediated transcription. J Biol Chem 278: 5427-5432.
25. Arvand A, Denny CT (2001) Biology of EWS/ETS fusions in Ewing's family tumors. Oncogene 20: 5747-5754.
26. Gascoyne DM, Thomas GR, Latchman DS (2004) The effects of Brn-3a on neuronal differentiation and apoptosis are differentially modulated by EWS and its oncogenic derivative EWS/Fli-1, Oncogene 23: 3830-3840.
27. Knoop LL, Baker SJ (2000) The splicing factor UIC represses EWS/ FLI-mediated transactivation. J Biol Chem 275: 24865-24871.
28. Yang L, Chansky HA, Hickstein DD (2000) EWS.Fli-1 fusion protein interacts with hyperphosphorylated RNA polymerase II and interferes with serine-arginine protein-mediated RNA splicing. J Biol Chem 275: 37612-37618.
29. Zhang D, Paley AJ, Childs G (1998) The transcriptional repressor ZFM1 interacts with and modulates the ability of EWS to activate transcription. J Biol Chem 273: 18086-18091.
30. Scotlandi K, Avnet S, Benini S, Manara MC, Serra M, et al. (2002) Expression of an IGF-I receptor dominant negative mutant induces apoptosis, inhibits tumorigenesis and enhances chemosensitivity in Ewing's sarcoma cells. Int J Cancer 101: 11-16.
31. Scotlandi K, Benini S, Nanni P, Lollini PL, Nicoletti G, et al. (1998) Blockage of insulin-like growth factor-I receptor inhibits the growth of Ewing's sarcoma in athymic mice. Cancer Res 58: 4127-4131.
32. Scotlandi K, Manara MC, Nicoletti G, Lollini PL, Lukas S, et al. (2005) Antitumor activity of the insulin-like growth factor-I receptor kinase inhibitor NVP-AEW541 in musculoskeletal tumors. Cancer Res 65: 3868-3876.
33. Toretsky JA, Kalebic T, Blakesley V, LeRoith D, Helman LJ (1997) The insulin-like growth factor-I receptor is required for EWS/FLI-1 transformation of fibroblasts. J Biol Chem 272: 30822-30827.
34. Prieur A, Tirode F, Cohen P, Delattre O (2004) EWS/FLI-1 silencing and gene profiling of Ewing cells reveal downstream oncogenic pathways and a crucial role for repression of insulin-like growth factor binding protein 3. Mol Cell Biol 24: 7275-7283.
35. Jiang Y, Jahagirdar BN, Reinhardt RL, Schwartz RE, Keene CD, et al. (2002) Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418: 41-49.
36. Suva D, Garavaglia G, Menetrey J, Chapuis B, Hoffmeyer P, et al. (2004) Non-hematopoietic human bone marrow contains long-lasting, pluripotential mesenchymal stem cells. J Cell Physiol 198: 110-118.
37. Suva D, Passweg J, Arnaudeau S, Hoffmeyer P, Kindler V (2007) In vitro activated human T lymphocytes very efficiently attach to allogenic multipotent mesenchymal stromal cells and transmigrate under them. J Cell Physiol.
38. Breitling R, Armengaud P, Amtmann A, Herzyk P (2004) Rank products: a simple, yet powerful, new method to detect differentially regulated genes in replicated microarray experiments. FEBS Lett 573: 83-92.
39. Hong F, Breitling R, McEntee CW, Wittner BS, Nemhauser JL, et al. (2006) RankProd: a bioconductor package for detecting differentially expressed genes in meta-analysis. Bioinformatics 22: 2825-2827.